Stockreport

GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythema...

GRI Bio, Inc.  (GRI) 
PDF Company reiterates 2024 as year of data Click here to watch the “What This Means” segment LA JOLLA, CA, May 22, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) [Read more]